Kyle Jenne Ionis Pharmaceuticals Inc (IONS) insider trading activity

IONS Quotes by TradingView

Kyle Jenne is EVP, Chf GL Pdt Str Ofcr of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 16,389 shares of IONS, which is worth approximately $1.17 Million. The most recent transaction as insider was on Jan 16, 2026, when has been sold 1,823 shares (Common Stock) at a price of $75.96 per share, resulting in proceeds of $138,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.4K
46.34% 3M change
n/a 12M change
Total Value Held $1.17 Million

Kyle Jenne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2026
SELL
Open market or private sale
$138,475 $75.96 p/Share
1,823 Reduced 10.01%
16,389 Common Stock
Jan 15 2026
BUY
Exercise of conversion of derivative security
-
7,013 Added 27.8%
18,212 Common Stock
Apr 16 2025
SELL
Open market or private sale
$85,533 $28.36 p/Share
3,016 Reduced 21.22%
11,199 Common Stock
Apr 15 2025
BUY
Exercise of conversion of derivative security
-
12,226 Added 46.24%
14,215 Common Stock
KJ

Kyle Jenne

EVP, Chf GL Pdt Str Ofcr
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IONS